Revolution Medicines (RVMD) News Today $38.16 -1.18 (-2.99%) As of 03:45 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Cibc World Markets Corp Makes New Investment in Revolution Medicines, Inc. (NASDAQ:RVMD)Cibc World Markets Corp acquired a new position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 15,664 shares of the company's stock, valued at apprMarch 23 at 3:52 AM | marketbeat.comProficio Capital Partners LLC Acquires New Shares in Revolution Medicines, Inc. (NASDAQ:RVMD)Proficio Capital Partners LLC acquired a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 17,146 shares of the company's stock, valued at approximately $750,000. Other hedgeMarch 23 at 3:10 AM | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) Receives Consensus Rating of "Buy" from AnalystsMarch 23 at 2:54 AM | americanbankingnews.comInsider Selling: Revolution Medicines, Inc. (NASDAQ:RVMD) CFO Sells 1,864 Shares of StockRevolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) CFO Jack Anders sold 1,864 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $39.04, for a total value of $72,770.56. Following the completion of the sale, the chief financial officer now owns 115,006 shares in the company, valued at approximately $4,489,834.24. The trade was a 1.59 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.March 20, 2025 | marketbeat.comInsider Selling: Revolution Medicines, Inc. (NASDAQ:RVMD) COO Sells 3,058 Shares of StockRevolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) COO Margaret A. Horn sold 3,058 shares of Revolution Medicines stock in a transaction on Monday, March 17th. The shares were sold at an average price of $39.04, for a total value of $119,384.32. Following the completion of the transaction, the chief operating officer now owns 153,533 shares of the company's stock, valued at approximately $5,993,928.32. This trade represents a 1.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.March 20, 2025 | marketbeat.comMark A. Goldsmith Sells 11,738 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) StockRevolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) insider Mark A. Goldsmith sold 11,738 shares of the company's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $39.04, for a total value of $458,251.52. Following the sale, the insider now owns 441,564 shares in the company, valued at $17,238,658.56. The trade was a 2.59 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.March 20, 2025 | marketbeat.comJack Anders Sells 1,864 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD) StockMarch 20, 2025 | insidertrades.comRaymond James Financial Inc. Invests $14.07 Million in Revolution Medicines, Inc. (NASDAQ:RVMD)Raymond James Financial Inc. bought a new position in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 321,611 shares of theMarch 19, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) Receives Average Recommendation of "Buy" from AnalystsShares of Revolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) have been given an average recommendation of "Buy" by the thirteen ratings firms that are presently covering the firm, MarketBeat Ratings reports. Twelve equities research analysts have rated the stock with a buy recommendation anMarch 18, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Boosts Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)Connor Clark & Lunn Investment Management Ltd. grew its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 674.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 208,401 shares of the company's stock after purchasing anMarch 16, 2025 | marketbeat.comRevolution Medicines’ SWOT analysis: RAS inhibitor stock shows promise amid clinical trialsMarch 14, 2025 | investing.comVictory Capital Management Inc. Trims Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)Victory Capital Management Inc. cut its position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 1.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 430,462 shaMarch 12, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Buys 167,997 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Charles Schwab Investment Management Inc. boosted its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 9.5% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,931,114 shares of the company's stocMarch 11, 2025 | marketbeat.comBank of New York Mellon Corp Has $24.89 Million Stock Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)Bank of New York Mellon Corp raised its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 6.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 569,015 shares of the company's stock after purcMarch 10, 2025 | marketbeat.comProficio Capital Partners LLC Purchases New Holdings in Revolution Medicines, Inc. (NASDAQ:RVMD)Proficio Capital Partners LLC acquired a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 17,146 shares of the company's stock, valued at approximately $75March 9, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) is Alphabet Inc.'s 4th Largest PositionAlphabet Inc. reduced its position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 2.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,133,277 shares of the compMarch 8, 2025 | marketbeat.comHC Wainwright Issues Pessimistic Forecast for RVMD EarningsRevolution Medicines, Inc. (NASDAQ:RVMD - Free Report) - HC Wainwright lowered their Q1 2025 earnings per share estimates for Revolution Medicines in a research report issued on Monday, March 3rd. HC Wainwright analyst R. Burns now forecasts that the company will post earnings per share of ($1.09March 7, 2025 | marketbeat.comE Fund Management Co. Ltd. Raises Stake in Revolution Medicines, Inc. (NASDAQ:RVMD)E Fund Management Co. Ltd. grew its stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 561.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 71,287 shares of the company's stock after purchasing an additionalMarch 7, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) Shares Bought by Candriam S.C.A.Candriam S.C.A. boosted its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 16.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 656,740 shares of the company's stock after purchasing aMarch 7, 2025 | marketbeat.comRevolution Medicines, Inc. (RVMD): Among the Cash-Rich Mid Cap Stocks to Buy NowMarch 3, 2025 | insidermonkey.comRevolution Medicines (NASDAQ:RVMD) Price Target Raised to $73.00HC Wainwright raised their target price on shares of Revolution Medicines from $72.00 to $73.00 and gave the stock a "buy" rating in a report on Monday.March 3, 2025 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: uniQure (QURE), Revolution Medicines (RVMD)March 3, 2025 | markets.businessinsider.comQ3 Earnings Estimate for RVMD Issued By Leerink PartnrsRevolution Medicines, Inc. (NASDAQ:RVMD - Free Report) - Analysts at Leerink Partnrs issued their Q3 2025 EPS estimates for Revolution Medicines in a research note issued to investors on Wednesday, February 26th. Leerink Partnrs analyst J. Chang anticipates that the company will earn ($1.18) perMarch 3, 2025 | marketbeat.comWedbush Lifts Earnings Estimates for Revolution MedicinesRevolution Medicines, Inc. (NASDAQ:RVMD - Free Report) - Equities researchers at Wedbush boosted their Q1 2025 earnings per share estimates for Revolution Medicines in a report released on Wednesday, February 26th. Wedbush analyst R. Driscoll now anticipates that the company will earn ($0.89) perMarch 3, 2025 | marketbeat.comNew York State Common Retirement Fund Buys 7,244 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)New York State Common Retirement Fund grew its stake in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 12.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 63,601 shares of the compaMarch 2, 2025 | marketbeat.comRevolution Medicines, Inc.: Revolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate ProgressMarch 1, 2025 | finanznachrichten.deRevolution Medicines (NASDAQ:RVMD) Given "Outperform" Rating at WedbushWedbush reaffirmed an "outperform" rating and issued a $67.00 price objective on shares of Revolution Medicines in a research report on Thursday.February 28, 2025 | marketbeat.comStifel Nicolaus Issues Pessimistic Forecast for Revolution Medicines (NASDAQ:RVMD) Stock PriceStifel Nicolaus cut their price target on shares of Revolution Medicines from $80.00 to $78.00 and set a "buy" rating on the stock in a report on Thursday.February 28, 2025 | marketbeat.comNeedham & Company LLC Has Lowered Expectations for Revolution Medicines (NASDAQ:RVMD) Stock PriceNeedham & Company LLC dropped their price objective on Revolution Medicines from $60.00 to $59.00 and set a "buy" rating for the company in a research report on Thursday.February 28, 2025 | marketbeat.comRevolution Medicines (NASDAQ:RVMD) Releases Quarterly Earnings Results, Misses Estimates By $0.11 EPSRevolution Medicines (NASDAQ:RVMD - Get Free Report) announced its quarterly earnings results on Wednesday. The company reported ($1.12) EPS for the quarter, missing the consensus estimate of ($1.01) by ($0.11).February 27, 2025 | marketbeat.comAnalysts Conflicted on These Healthcare Names: Revolution Medicines (RVMD) and Genmab (GMAB)February 27, 2025 | markets.businessinsider.comRevolution Medicines reports Q4 EPS ($1.12), consensus (96c)February 26, 2025 | markets.businessinsider.comRevolution Medicines sees FY25 GAAP net loss $840M-$900MFebruary 26, 2025 | markets.businessinsider.comRevolution Medicines Reports Fourth Quarter and Full Year 2024 Financial Results and Update on Corporate ProgressFebruary 26, 2025 | globenewswire.comRevolution Medicines to Participate in March 2025 Investor ConferencesFebruary 24, 2025 | globenewswire.com62,161 Shares in Revolution Medicines, Inc. (NASDAQ:RVMD) Bought by HealthInvest Partners ABHealthInvest Partners AB acquired a new stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 62,161 shares of the company's stockFebruary 24, 2025 | marketbeat.comRhumbline Advisers Acquires 24,473 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)Rhumbline Advisers raised its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 10.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 251,465 shares of the company's stock after purchasing an additFebruary 24, 2025 | marketbeat.comAllspring Global Investments Holdings LLC Grows Position in Revolution Medicines, Inc. (NASDAQ:RVMD)Allspring Global Investments Holdings LLC increased its position in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 54.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 59,743 shares of the company'sFebruary 22, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Recommendation of "Buy" by BrokeragesRevolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) has been assigned a consensus recommendation of "Buy" from the twelve brokerages that are currently covering the company, Marketbeat reports. Eleven investment analysts have rated the stock with a buy rating and one has assigned a strongFebruary 21, 2025 | marketbeat.comRevolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2024 After Market Close on February 26, 2025February 19, 2025 | globenewswire.comRevolution Medicines (RVMD) Projected to Post Earnings on MondayRevolution Medicines (NASDAQ:RVMD) will be releasing earnings before the market opens on Monday, February 24, Financial Modeling Prep reports.February 17, 2025 | marketbeat.comRevolution Medicines, Inc. (NASDAQ:RVMD) Stake Cut by Wilmington Savings Fund Society FSBWilmington Savings Fund Society FSB cut its position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 85.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,500 shares of the company's stock aftFebruary 14, 2025 | marketbeat.comEmpowered Funds LLC Purchases Shares of 132,679 Revolution Medicines, Inc. (NASDAQ:RVMD)Empowered Funds LLC acquired a new position in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 132,679 shares of the company's stock, valued at approximately $5,803,00February 12, 2025 | marketbeat.comSG Americas Securities LLC Sells 28,515 Shares of Revolution Medicines, Inc. (NASDAQ:RVMD)SG Americas Securities LLC reduced its position in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 90.7% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,939 shares of the company's stock after selling 28,515 shares during the period. SG AmFebruary 12, 2025 | marketbeat.comWingate Wealth Advisors Inc. Buys New Position in Revolution Medicines, Inc. (NASDAQ:RVMD)Wingate Wealth Advisors Inc. purchased a new position in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 10,000 shares of the company's stock, valued at approximately $437,February 10, 2025 | marketbeat.com157,477 Shares in Revolution Medicines, Inc. (NASDAQ:RVMD) Purchased by WCM Investment Management LLCWCM Investment Management LLC acquired a new stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 157,477 shares of the company's stock, valued at approximately $6,798,000. WCM InvesFebruary 10, 2025 | marketbeat.comWhy Revolution Medicines, Inc. (RVMD) Is Among the Best Healthcare Stocks To Buy According to AnalystsFebruary 8, 2025 | msn.comChina Universal Asset Management Co. Ltd. Has $2.71 Million Position in Revolution Medicines, Inc. (NASDAQ:RVMD)China Universal Asset Management Co. Ltd. lifted its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 92.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 61,980 shares of theFebruary 1, 2025 | marketbeat.comRevolution Medicines to Participate in the Guggenheim Securities SMID Cap Biotech ConferenceJanuary 29, 2025 | globenewswire.comRevolution Medicines, Inc. (NASDAQ:RVMD) Receives Average Recommendation of "Buy" from BrokeragesRevolution Medicines, Inc. (NASDAQ:RVMD - Get Free Report) has been assigned a consensus recommendation of "Buy" from the twelve ratings firms that are covering the stock, MarketBeat Ratings reports. Eleven equities research analysts have rated the stock with a buy recommendation and one has givenJanuary 27, 2025 | marketbeat.com Remove Ads Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMD and its competitors with MarketBeat's FREE daily newsletter. Email Address RVMD Media Mentions By Week RVMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RVMD News Sentiment▼0.650.63▲Average Medical News Sentiment RVMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RVMD Articles This Week▼115▲RVMD Articles Average Week Remove Ads Get Revolution Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for RVMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ONC News BNTX News TEVA News SMMT News ITCI News MRNA News GMAB News RDY News VTRS News ASND News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RVMD) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revolution Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revolution Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RVMD Stock Free RVMD Stock Alerts